9th Tumor Models San Francisco Summit 2025, January 29-30, 2025

Conference

genOway presentation

Event
-
January 22, 2025

genOway's presentation on Wednesday, January 29, 2025 | 4 p.m. PST:

Assessment of translational tumor biology and efficacy in humanized mouse models

  • Outlining BRGSF-HIS mice: a CD34+-reconstituted model with functional human lymphoid and myeloid compartments without side effects
  • Investigating human immune cell recruitment into tumor microenvironment in BRGSF-HIS mice
  • Assessment of anti-tumoral compounds in BRGSF-HIS mice
  • Use of hFcγR model to investigate the Fc-mediate effector functions of therapeutic antibodies

9th Tumor Models San Francisco Summit 2025, January 29-30, 2025

Get in touch

Let us know how we can help

Other news & events

14th Tumour Models Summit London 2025, December 3-4, 2025
Conference
genOway presentation
Event
-
Dec 2025
Read on
genOway Shanghai at the 16th China International Pharmaceutical Expo 2025
Conference
Event
-
Nov 2025
Read on
7th Myeloid-Directed Summit 2025, November 18-20, 2025
Conference
genOway presentation
Event
-
Nov 2025
Read on
40th SITC meeting 2025, National Harbor, MD, November 5-9
Conference
genOway presentation
Event
-
Nov 2025
Read on
genOway Shanghai at BIONNOVA Beijing Forum 2025
Conference
Event
-
Sep 2025
Read on
Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe